Literature DB >> 15634900

Role of CD28 in polyclonal and specific T and B cell responses required for protection against blood stage malaria.

Rosa M Elias1, Luiz R Sardinha, Karina R B Bastos, Cláudia A Zago, Ana Paula Freitas da Silva, José M Alvarez, Maria Regina D'Império Lima.   

Abstract

The role of B7/CD28 costimulatory pathway in the polyclonal and specific lymphocyte activation induced by blood stages of Plasmodium chabaudi AS was investigated in CD28 gene knockout (CD28(-/-)) and C57BL/6 (CD28(+/+)) mice. Analysis of the spleen during the acute infection revealed a similar increase in T and B cell populations in both groups of mice. Moreover, CD28(-/-) mice were able to develop a polyclonal IgM response to P. chabaudi. On the contrary, the polyclonal IgG2a response was markedly reduced in the absence of CD28. Production of IFN-gamma; up-regulation of CD69, CD40L, CD95 (Fas), and CD95L (Fas ligand); and induction of apoptosis were also affected by the lack of CD28. Interestingly, the ability to control the first parasitemia peak was not compromised in acutely infected CD28(-/-) mice, but CD28(-/-) mice failed to eradicate the parasites that persisted in the blood for >3 mo after infection. In addition, drug-cured CD28(-/-) mice were unable to generate memory T cells, develop an anamnesic IgG response, or eliminate the parasites from a secondary challenge. The incapacity of CD28(-/-) mice to acquire a full protective immunity to P. chabaudi correlated with an impaired production of specific IgG2a. Moreover, reinfected CD28(-/-) mice were protected by the adoptive transfer of serum from reinfected CD28(+/+) mice containing specific IgG2a. Our results demonstrate that the polyclonal lymphocyte response is only partially affected by the absence of CD28, but this coreceptor is essential to generate specific T and B cell responses required for complete protection against P. chabaudi malaria.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15634900     DOI: 10.4049/jimmunol.174.2.790

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Comparative analysis of activation phenotype, proliferation, and IFN-gamma production by spleen NK1.1(+) and NK1.1(-) T cells during Plasmodium chabaudi AS malaria.

Authors:  Sandra Marcia Muxel; Ana Paula Freitas do Rosário; Luiz Roberto Sardinha; Sheyla Inés Castillo-Méndez; Cláudia Augusta Zago; Sérgio Marcelo Rodriguez-Málaga; José Maria Alvarez Mosig; Maria Regina D'Império Lima
Journal:  J Interferon Cytokine Res       Date:  2010-06       Impact factor: 2.607

2.  Challenge of chronically infected mice with homologous trypanosoma cruzi parasites enhances the immune response but does not modify cardiopathy: implications for the design of a therapeutic vaccine.

Authors:  Christian Emerson Rosas-Jorquera; Luiz Roberto Sardinha; Fernando Delgado Pretel; André Luis Bombeiro; Maria Regina D'Império Lima; José Maria Alvarez
Journal:  Clin Vaccine Immunol       Date:  2012-12-19

3.  Distinct roles of CD28- and CD40 ligand-mediated costimulation in the development of protective immunity and pathology during Chlamydia muridarum urogenital infection in mice.

Authors:  Lili Chen; Wen Cheng; Pooja Shivshankar; Lei Lei; Xiaoyun Zhang; Yimou Wu; I-Tien Yeh; Guangming Zhong
Journal:  Infect Immun       Date:  2009-04-27       Impact factor: 3.441

4.  Reduced protective efficacy of a blood-stage malaria vaccine by concurrent nematode infection.

Authors:  Zhong Su; Mariela Segura; Mary M Stevenson
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

Review 5.  Using two phases of the CD4 T cell response to blood-stage murine malaria to understand regulation of systemic immunity and placental pathology in Plasmodium falciparum infection.

Authors:  Komi Gbedande; Victor H Carpio; Robin Stephens
Journal:  Immunol Rev       Date:  2020-01       Impact factor: 12.988

6.  The spleen CD4+ T cell response to blood-stage Plasmodium chabaudi malaria develops in two phases characterized by different properties.

Authors:  Sandra Marcia Muxel; Ana Paula Freitas do Rosário; Cláudia Augusta Zago; Sheyla Inés Castillo-Méndez; Luiz Roberto Sardinha; Sérgio Marcelo Rodriguez-Málaga; Niels Olsen Saraiva Câmara; José Maria Álvarez; Maria Regina D'Império Lima
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

7.  Anti-IL-2 treatment impairs the expansion of T(reg) cell population during acute malaria and enhances the Th1 cell response at the chronic disease.

Authors:  Cláudia A Zago; Karina R Bortoluci; Luiz R Sardinha; Fernando D Pretel; Sheyla I Castillo-Méndez; Ana Paula Freitas do Rosário; Meire I Hiyane; Sandra M Muxel; Sérgio M Rodriguez-Málaga; Ises A Abrahamsohn; José M Álvarez; Maria Regina D'Império Lima
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

8.  IFNγ and IL-12 Restrict Th2 Responses during Helminth/Plasmodium Co-Infection and Promote IFNγ from Th2 Cells.

Authors:  Stephanie M Coomes; Victoria S Pelly; Yashaswini Kannan; Isobel S Okoye; Stephanie Czieso; Lewis J Entwistle; Jimena Perez-Lloret; Nikolay Nikolov; Alexandre J Potocnik; Judit Biró; Jean Langhorne; Mark S Wilson
Journal:  PLoS Pathog       Date:  2015-07-06       Impact factor: 6.823

9.  Angiotensin II is a new component involved in splenic T lymphocyte responses during Plasmodium berghei ANKA infection.

Authors:  João Luiz Silva-Filho; Mariana Conceição Souza; Claudio Teixeira Ferreira-Dasilva; Leandro Souza Silva; Maria Fernanda Souza Costa; Tatiana Almeida Padua; Maria das Graças Henriques; Alexandre Morrot; Wilson Savino; Celso Caruso-Neves; Ana Acacia Sá Pinheiro
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

Review 10.  Splenic Macrophage Subsets and Their Function during Blood-Borne Infections.

Authors:  Henrique Borges da Silva; Raíssa Fonseca; Rosana Moreira Pereira; Alexandra Dos Anjos Cassado; José Maria Álvarez; Maria Regina D'Império Lima
Journal:  Front Immunol       Date:  2015-09-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.